...
首页> 外文期刊>Vaccine >HPV vaccine and adolescent males
【24h】

HPV vaccine and adolescent males

机译:HPV疫苗和青春期男性

获取原文
获取原文并翻译 | 示例
           

摘要

In 2009, the United States approved quadrivalent HPV vaccine for males 9-26 years old, but data on vaccine uptake are lacking. We determined HPV vaccine uptake among adolescent males, as well as stage of adoption and vaccine acceptability to parents and their sons. A national sample of parents of adolescent males ages 11-17 years (n = 547) and their sons (n = 421) completed online surveys during August and September 2010. Analyses used multivariate linear regression. Few sons (2%) had received any doses of HPV vaccine, and most parents and sons were unaware the vaccine can be given to males. Parents with unvaccinated sons were moderately willing to get their sons free HPV vaccine (mean = 3.37, SD = 1.21, possible range 1-5). Parents were more willing to get their sons vaccinated if they perceived higher levels of HPV vaccine effectiveness (beta=0.20) or if they anticipated higher regret about their sons not getting vaccinated and later developing an HPV infection (beta=0.32). Vaccine acceptability was also modest among unvaccinated sons (mean = 2.98, SD = 1.13, possible range 1-5). Sons were more willing to get vaccinated if they perceived higher peer acceptance of HPV vaccine (beta=0.39) or anticipated higher regret about not getting vaccinated and later developing an HPV infection (beta=0.22). HPV vaccine uptake was nearly nonexistent a year after permissive national recommendations were first issued for males. Vaccine acceptability was moderate among both parents and sons. Efforts to increase vaccine uptake among adolescent males should consider the important role of peer acceptance and anticipated regret
机译:2009年,美国批准了9至26岁男性的四价HPV疫苗,但缺乏疫苗吸收数据。我们确定了青春期男性的HPV疫苗摄入量,以及父母和儿子的收养阶段和疫苗可接受性。全国范围内的11至17岁青少年男性父母(n = 547)和其儿子(n = 421)的样本在2010年8月和9月间完成了在线调查。分析使用了多元线性回归。很少有儿子(2%)接受过任何剂量的HPV疫苗,大多数父母和儿子都不知道该疫苗可用于男性。儿子未接种疫苗的父母较愿意为儿子提供免费的HPV疫苗(平均值= 3.37,SD = 1.21,可能范围1-5)。如果父母对HPV疫苗的有效性更高(β= 0.20),或者对儿子未接种疫苗并后来发展为HPV感染(β= 0.32)感到更加遗憾,他们更愿意给儿子接种疫苗。在未接种疫苗的儿子中,疫苗的可接受性也很低(平均值= 2.98,SD = 1.13,可能范围1-5)。如果儿子对同龄人接受HPV疫苗的接受程度更高(β= 0.39),或者对未接种疫苗并后来发展为HPV感染(β= 0.22)有更高的遗憾,则儿子们更愿意接种疫苗。在首次针对男性发布允许的国家建议后一年,几乎没有HPV疫苗的摄入。父母和儿子的疫苗可接受性中等。努力增加青春期男性的疫苗摄入量,应考虑同龄人接受的重要作用,并预期会有遗憾

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号